EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
Edwards Lifesciences Corp (EW) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.25B | $1.35B | $1.40B | $1.62B | $1.77B | $1.98B | $2.22B | $2.72B | $3.52B | $4.06B | $4.51B | $5.70B | $5.32B | $6.49B | $7.24B | $8.50B | $8.29B | $9.36B | $13.06B | — |
| Cash & equivalents | $182.80M | $141.80M | $218.70M | $334.10M | $396.10M | $171.20M | $310.90M | $420.40M | $653.80M | $718.40M | $930.10M | $818.30M | $714.10M | $1.18B | $1.18B | $862.80M | $769.00M | $1.13B | $3.05B | — |
| Current assets | $531.60M | $581.70M | $691.90M | $889.20M | $1.03B | $1.17B | $1.29B | $1.73B | $2.29B | $2.05B | $2.24B | $2.53B | $2.29B | $2.98B | $3.09B | $3.18B | $3.10B | $4.04B | $6.29B | — |
| Total liabilities | $497.40M | $510.10M | $521.40M | $457.60M | $459.00M | $642.60M | $742.20M | $1.17B | $1.33B | $1.56B | $1.89B | $2.70B | $2.18B | $2.34B | $2.66B | $2.67B | $2.49B | $2.64B | $2.99B | — |
| Current liabilities | $226.20M | $375.40M | $258.50M | $290.50M | $337.80M | $335.20M | $347.40M | $345.60M | $434.40M | $476.20M | $532.50M | $1.40B | $876.60M | $902.40M | $893.90M | $1.03B | $1.02B | $1.20B | $1.51B | — |
| Long-term debt | $235.90M | $61.70M | $175.50M | $90.30M | $0.00 | $150.40M | $189.30M | $593.10M | $598.10M | $596.90M | $822.30M | $438.40M | $593.80M | $594.40M | $595.00M | $595.70M | $596.30M | $597.00M | $597.70M | — |
| Shareholder equity | $749.40M | $835.00M | $878.80M | $1.16B | $1.31B | $1.34B | $1.48B | $1.56B | $2.19B | $2.50B | $2.62B | $2.99B | $3.14B | $4.15B | $4.57B | $5.84B | $5.81B | $6.65B | $10.00B | — |
| Retained earnings | $433.90M | $548.60M | $676.90M | $906.00M | $1.12B | $1.36B | $1.65B | $2.05B | $2.84B | $3.34B | $3.91B | $2.00B | $2.69B | $3.74B | $4.57B | $6.07B | $7.59B | $8.99B | $13.17B | — |
| Accounts receivable | $127.10M | $145.30M | $204.70M | $272.10M | $302.50M | $320.70M | $347.50M | $328.00M | $325.00M | $344.10M | $414.60M | $479.30M | $537.30M | $599.10M | $602.80M | $664.90M | $699.10M | $828.10M | $727.40M | — |
| Inventory | $142.10M | $152.60M | $151.80M | $165.90M | $203.60M | $261.30M | $281.00M | $308.90M | $296.80M | $339.90M | $396.60M | $554.90M | $607.00M | $640.90M | $802.30M | $726.70M | $875.50M | $903.50M | $1.09B | — |
| Goodwill | $337.70M | $350.30M | $315.70M | $315.20M | $315.20M | $349.80M | $384.70M | $385.40M | $376.00M | $628.30M | $626.10M | $1.13B | $1.11B | $1.17B | $1.17B | $1.17B | $1.16B | $1.15B | $1.78B | — |